Business Description
GeNeuro SA
ISIN : CH0308403085
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.58 | |||||
Equity-to-Asset | -0.45 | |||||
Debt-to-Equity | -2.31 | |||||
Debt-to-EBITDA | -1.03 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 6.3 | |||||
3-Year EPS without NRI Growth Rate | 7.8 | |||||
3-Year FCF Growth Rate | 6.5 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 39.3 | |||||
9-Day RSI | 53.29 | |||||
14-Day RSI | 58.15 | |||||
6-1 Month Momentum % | 6.56 | |||||
12-1 Month Momentum % | -33.84 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.08 | |||||
Quick Ratio | 2.08 | |||||
Cash Ratio | 1.59 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -19.5 | |||||
Shareholder Yield % | -13.18 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -1114.26 | |||||
ROA % | -100.79 | |||||
ROIC % | -261.26 | |||||
ROC (Joel Greenblatt) % | -1014.07 | |||||
ROCE % | -135.32 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -3.75 | |||||
EV-to-EBITDA | -3.84 | |||||
EV-to-FCF | -3.11 | |||||
Earnings Yield (Greenblatt) % | -26.67 | |||||
FCF Yield % | -36.19 |